Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review

Background and objective: Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a chronic inflammatory disorder characterized by aberrant immune responses and compromised barrier function in the gastrointestinal tract. IBD is associated with altered gut microbiota and their metabolites in the colon. Butyrate, a gut microbial metabolite, plays a crucial role in regulating immune function, epithelial barrier function, and intestinal homeostasis. In this review, we aim to present an overview of butyrate synthesis and metabolism and the mechanism of action of butyrate in maintaining intestinal homeostasis and to discuss the therapeutic implications of butyrate in IBD. Methods: We searched the literature up to March 2023 through PubMed, Web of Science, and other sources using search terms such as butyrate, inflammation, IBD, Crohn’s disease, and ulcerative colitis. Clinical studies in patients and preclinical studies in rodent models of IBD were included in the summary of the therapeutic implications of butyrate. Results: Research in the last two decades has shown the beneficial effects of butyrate on gut immune function and epithelial barrier function. Most of the preclinical and clinical studies have shown the positive effect of butyrate oral supplements in reducing inflammation and maintaining remission in colitis animal models and IBD patients. However, butyrate enema showed mixed effects. Butyrogenic diets, including germinated barley foodstuff and oat bran, are found to increase fecal butyrate concentrations and reduce the disease activity index in both animal models and IBD patients. Conclusions: The current literature suggests that butyrate is a potential add-on therapy to reduce inflammation and maintain IBD remission. Further clinical studies are needed to determine if butyrate administration alone is an effective therapeutic treatment for IBD.

• Publication year

  2023

• Venue

  Nutrients

• Publication date

  2023-05-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3390/nu15102275PMID 37242159PMCID 10221771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quinoa bran soluble dietary fiber ameliorates dextran sodium sulfate induced ulcerative colitis in BALB/c mice by maintaining intestinal barrier function and modulating gut microbiota.

  2022cited by this paper
• Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis

  2022cited by this paper
• Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases—Randomized Placebo-Controlled Multicenter Trial

  2022cited by this paper
• The Peanut Skin Procyanidins Attenuate DSS-Induced Ulcerative Colitis in C57BL/6 Mice

  2022cited by this paper
• Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles

  2022cited by this paper
• Butyl-fructooligosaccharides modulate gut microbiota in healthy mice and ameliorate ulcerative colitis in a DSS-induced model.

  2022cited by this paper
• Oat β-glucan alleviates DSS-induced colitis via regulating gut microbiota metabolism in mice.

  2021cited by this paper
• Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients

  2021cited by this paper
• β-Glucan Extracted from Highland Barley Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in C57BL/6J Mice

  2021cited by this paper
• Resolving the Contradictory Functions of Lysine Decarboxylase and Butyrate in Periodontal and Intestinal Diseases

  2021cited by this paper
• Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model.

  2021cited by this paper
• Sodium Butyrate Alleviates Mouse Colitis by Regulating Gut Microbiota Dysbiosis

  2020cited by this paper
• The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study

  2020cited by this paper
• Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: A therapeutic target to control intestinal inflammation

  2020cited by this paper
• Short chain fatty acids in human gut and metabolic health.

  2020cited by this paper
• Flaxseed oligosaccharides alleviate DSS-induced colitis through modulation of gut microbiota and repair of the intestinal barrier in mice.

  2020cited by this paper
• Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

  2020cited by this paper
• Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial

  2020cited by this paper
• Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells' Differentiation and Function in Induction of Colitis.

  2019cited by this paper
• Bridging intestinal immunity and gut microbiota by metabolites

  2019cited by this paper
• The role of short-chain fatty acids in microbiota–gut–brain communication

  2019cited by this paper
• Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells

  2019cited by this paper
• Butyrate Protects Mice from Clostridium difficile-Induced Colitis through an HIF-1-Dependent Mechanism.

  2019cited by this paper
• Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria

  2019cited by this paper
• Dietary interventions for induction and maintenance of remission in inflammatory bowel disease.

  2019cited by this paper
• Commensal-bacteria-derived butyrate promotes the T cell-independent IgA response in the colon.

  2019cited by this paper
• An orally administered butyrate-releasing xylan derivative reduces inflammation in dextran sulphate sodium-induced murine colitis.

  2019cited by this paper
• Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

  2018cited by this paper
• Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model

  2018cited by this paper
• Butyrate: A Double-Edged Sword for Health?

  2018cited by this paper
• Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles

  2018cited by this paper
• Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity

  2018cited by this paper
• Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines

  2018cited by this paper
• Microbial-Derived Butyrate Promotes Epithelial Barrier Function through IL-10 Receptor–Dependent Repression of Claudin-2

  2017cited by this paper
• Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis

  2017cited by this paper
• Systemic availability and metabolism of colonic‐derived short‐chain fatty acids in healthy subjects: a stable isotope study

  2017cited by this paper
• Intestinal barrier and gut microbiota: Shaping our immune responses throughout life

  2017cited by this paper
• Short Chain Fatty Acids Enhance Aryl Hydrocarbon (Ah) Responsiveness in Mouse Colonocytes and Caco-2 Human Colon Cancer Cells

  2017cited by this paper
• An orally administered butyrate‐releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium‐induced murine colitis

  2017cited by this paper
• Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease

  2017cited by this paper
• Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway

  2017cited by this paper
• Sodium butyrate inhibits the NF‐kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL‐10 independent manner

  2017cited by this paper
• Gut microbiota, metabolites and host immunity

  2016cited by this paper
• Experimental and Pathalogical study of Pistacia atlantica, butyrate, Lactobacillus casei and their combination on rat ulcerative colitis model.

  2016cited by this paper
• Host-microbiome interactions: the aryl hydrocarbon receptor and the central nervous system

  2016cited by this paper
• Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats

  2016influential reference
• Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal

  2015cited by this paper
• The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition

  2014cited by this paper
• Intestinal epithelial cells: regulators of barrier function and immune homeostasis

  2014cited by this paper
• Fiber in the Treatment and Maintenance of Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials

  2014cited by this paper
• Intestinal Inflammation and Mucosal Barrier Function

  2014cited by this paper
• The gut microbiota, bacterial metabolites and colorectal cancer

  2014cited by this paper
• Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic Data

  2014cited by this paper
• Characterization of butyrate transport across the luminal membranes of equine large intestine

  2014cited by this paper
• Epithelial Transport in Inflammatory Bowel Diseases

  2014cited by this paper
• Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.

  2014cited by this paper
• Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

  2013cited by this paper
• American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.

  2013cited by this paper
• Modulation of the microbial fermentation in the gut by fermentable carbohydrates

  2013cited by this paper
• A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

  2013cited by this paper
• Butyrate Enhances Intestinal Epithelial Barrier Function via Up-Regulation of Tight Junction Protein Claudin-1 Transcription

  2012cited by this paper
• Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.

  2012cited by this paper
• CD4+T Cells: Differentiation and Functions

  2012cited by this paper
• Diversity, stability and resilience of the human gut microbiota

  2012cited by this paper
• Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis.

  2012cited by this paper
• Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7α-dehydroxylating intestinal bacterium

  2012cited by this paper
• Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics

  2012cited by this paper
• Intestinal homeostasis and its breakdown in inflammatory bowel disease

  2011cited by this paper
• Enterocyte death and intestinal barrier maintenance in homeostasis and disease.

  2011cited by this paper
• Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission.

  2010cited by this paper
• From the gut to the peripheral tissues: the multiple effects of butyrate

  2010cited by this paper
• The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects

  2010cited by this paper
• The prebiotic, oligofructose-enriched inulin modulates the faecal metabolite profile: an in vitro analysis.

  2010cited by this paper
• Low counts of Faecalibacterium prausnitzii in colitis microbiota

  2009cited by this paper
• The regulation of the intestinal mucin MUC2 expression by short chain fatty acids: implications for epithelial protection

  2009cited by this paper
• Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine.

  2009cited by this paper
• Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

  2009cited by this paper
• Role of the intestinal barrier in inflammatory bowel disease.

  2008cited by this paper
• Role of the intestinal barrier in inflammatory bowel disease

  2007cited by this paper
• Effects of Butyrate on Intestinal Barrier Function in a Caco-2 Cell Monolayer Model of Intestinal Barrier

  2007cited by this paper
• Unravelling the pathogenesis of inflammatory bowel disease

  2007cited by this paper
• The Immune Response in Inflammatory Bowel Disease

  2007cited by this paper
• Efficacy of butyrate in the treatment of mild to moderate Crohn's disease

  2007cited by this paper
• Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005.

  2006cited by this paper
• Colonic Health: Fermentation and Short Chain Fatty Acids

  2006cited by this paper
• Antigen sampling by mucosal dendritic cells.

  2005cited by this paper
• Histochemical demonstration of a Na(+)-coupled transporter for short-chain fatty acids (slc5a8) in the intestine and kidney of the mouse.

  2005cited by this paper
• Oral butyrate for mildly to moderately active Crohn's disease

  2005cited by this paper
• Oral tolerance and its relation to food hypersensitivities.

  2005cited by this paper
• Germinated barley foodstuff prolongs remission in patients with ulcerative colitis.

  2004cited by this paper
• The immunological and genetic basis of inflammatory bowel disease

  2003cited by this paper
• Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF- B

  2003cited by this paper
• Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-kappaB.

  2003cited by this paper
• Increasing Fecal Butyrate in Ulcerative Colitis Patients by Diet: Controlled Pilot Study

  2003cited by this paper
• Variable Effects of Short Chain Fatty Acids and Lactic Acid in Inducing Intestinal Mucosal Injury in Newborn Rats

  2002cited by this paper
• Butyrate Inhibits NF-κB Activation in Lamina Propria Macrophages of Patients with Ulcerative Colitis

  2002cited by this paper
• Butyrate Suppression of Colonocyte NF-κB Activation and Cellular Proteasome Activity*

  2001cited by this paper
• Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.

  2001cited by this paper
• The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line.

  2000cited by this paper
• Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.

  2000cited by this paper

• Sodium butyrate augments the antibacterial activity of tetracycline against clinical isolates of multidrug-resistant Vibrio cholerae

  2026cites this paper
• Porphyromonas gingivalis is a key periodontal pathogen in the relationship between periodontal and gastroenterological diseases

  2026cites this paper
• Mechanistic insights into cordycepin-enhanced CTLA-4 blockade efficacy via Eubacterium rectale-mediated immunomodulation in colon cancer.

  2026cites this paper
• Insights into the mechanism of treatment of ulcerative colitis with pre- and post-processed dried ginger through perspective of metabolomics and intestinal microbiomics research.

  2026cites this paper
• Protective role of aqueous Coriandrum sativum seed extract in diet-induced glucolipid metabolic disorder through gut-liver axis regulation.

  2026cites this paper
• Reconsidering the clinical implications of oral butyrate supplementation in inflammatory bowel disease.

  2026cites this paper
• Ferroptosis as a mediator of gut microbiota-driven inflammatory bowel disease: Evidence from genetic analyses

  2026cites this paper
• Modulation of gut microbiota and short-chain fatty acids by probiotics attenuates inflammation in endometriosis

  2026cites this paper
• Butyrate-Producing Bacteria as a Keystone Species of the Gut Microbiome: A Systemic Review of Dietary Impact on Gut–Brain and Host Health

  2026cites this paper
• An in situ therapeutic vaccine for targeted treatment of ulcerative colitis via induction and maintenance of long-term immune tolerance

  2026cites this paper
• Lactiplantibacillus plantarum LPPerfectus001 Alleviating Irritable Bowel Syndrome in Mice by Modulating Gut Microbiota and NF-κB Signaling Pathway

  2026cites this paper
• Harnessing meat byproducts for health: bioactive peptides to modulate gut microbiota and promote sustainability

  2026cites this paper
• Therapeutic potential of butyrate supplementation in sepsis: a review of preclinical evidence and translational perspectives.

  2026cites this paper
• Approach to Malnutrition and Oral Nutrition Therapy in Adults with IBD: What to Consider

  2026cites this paper
• Multi-omics reveals co-regulation of hepatic bile acid metabolism in laying hens by host genetics and the cecal Anaerostipes

  2026cites this paper
• Metabolic reprogramming as a therapeutic target for modulating the Th17/Treg balance in autoimmune diseases: a comprehensive review

  2025cites this paper
• The association between dietary fiber intake and pelvic inflammatory disease in women: findings from the NHANES 2015–2018

  2025cites this paper
• The Therapeutic Potential of Butyrate and Lauric Acid in Modulating Glial and Neuronal Activity in Alzheimer’s Disease

  2025cites this paper
• Tricobalt tetraselenide nanoparticles improve intestinal barrier function by reshaping the gut microbiota and fortifying epithelial tight junctions.

  2025cites this paper
• Xiaoyu Xiezhuo Decoction Ameliorates Tubulointerstitial Fibrosis by Modulating Gut–Kidney Axis and Aldosterone Signaling Pathway in UUO Rats

  2025cites this paper
• Effect of Acute Gut Butyrate Delivery on Blood Pressure in Black Individuals With Hypertension: A Proof‐of‐Concept Randomized Controlled Study

  2025cites this paper
• A butyrate‐producing synbiotic mitigates intestinal inflammation in a murine colitis model

  2025cites this paper
• Hydrogen Sulfide Has a Minor Impact on Human Gut Microbiota Across Age Groups

  2025cites this paper
• Enemas with sucralfate and n-acetylcysteine can reduce inflammation and oxidative stress in colonic mucosa without fecal stream

  2025cites this paper
• Metal-Organic Framework-Remodeled Gut Microbiota Alleviates Colonic Inflammation via Selective Modulation of Roseburia intestinalis.

  2025cites this paper
• Probiotic and Vitamin D Ameliorate TNBS-Induced Colitis by Targeting Mucosal Barrier and Neutrophil Infiltration

  2025cites this paper
• HIV-associated gut dysbiosis drives oncogenesis through metabolic-immune crosstalk: mechanisms and therapeutic implications

  2025cites this paper
• Gut Microbiota in Acute Myeloid Leukemia: From Biomarkers to Interventions

  2025cites this paper
• Dual-Targeting Mn@CeO2 Nanozyme-Modified Probiotic Hydrogel Microspheres Reshape Gut Homeostasis in Inflammatory Bowel Disease

  2025cites this paper
• Octenyl Succinic Anhydride Starch Alleviates Alcoholic Liver Disease by Modulating Gut Microbiota and Metabolism

  2025cites this paper
• Gut Dysbiosis Driven by CFTR Gene Mutations in Cystic Fibrosis Patients: From Genetic Disruption to Multisystem Consequences and Microbiota Modulation

  2025cites this paper
• The role of active constituents of in traditional Chinese medicine for primary osteoporosis: a mechanistic review

  2025cites this paper
• Examining the role of faecal microbiota transplantation for inducing remission in resistant ulcerative proctitis and distal ulcerative colitis (up-FMT).

  2025cites this paper
• The impact of three distinct probiotic supplements on the gut microbiota and its metabolites in healthy adults.

  2025cites this paper
• Mechanism by which porcine transmissible gastroenteritis virus disrupts host innate immunity

  2025cites this paper
• Pharmacological Potential of Arthrospira platensis in Mitigating Sub-Chronic Colitis: Redox Homeostasis and Gut Microbiota Modulation

  2025cites this paper
• Effect of fucoidan molecular weight on gut microbiota composition and anti-inflammatory activity after in vitro dynamic digestion and fermentation.

  2025cites this paper
• Clostridium butyricum MIYAIRI 588 Reduces Colorectal Adenomatous Polyp Recurrence: A Randomized Crossover Trial

  2025cites this paper
• Oral Carbon Dots Derived from Cimicifugae rhizome Carbonization Products to Ameliorate Ulcerative Colitis.

  2025cites this paper
• “The Holobiont as a Biosemiotic System: Health and Dysbiosis Signals in the Human Gut Microbiome”

  2025influential citation
• Short-chain fatty acids in the treatment of ulcerative colitis. Systematic review and meta-analysis

  2025cites this paper
• Baseline Fusobacterium Abundance Predicts Ustekinumab Response in Crohn's Disease: A Prospective Microbiome Cohort Study

  2025cites this paper
• Lily polysaccharides alleviate colitis through the microbiota–N8-acetylspermidine–cGAS–STING signaling axis

  2025cites this paper
• Gut microbiome in IBD: past, present and the future

  2025cites this paper
• Exploring the microbial basis of postbiotic and paraprobiotic therapy in ulcerative colitis

  2025cites this paper
• Research progress concerning the involvement of the intestinal microbiota in the occurrence and development of inflammatory bowel disease

  2025cites this paper
• Tectorigenin alleviates diabetic lung injury by restoring gut microbiota and metabolic homeostasis.

  2025cites this paper
• Brown fermented milk alleviates diarrhea via unique metabolomic mechanisms

  2025cites this paper
• Shengjiang San attenuates sepsis-induced acute intestinal injury via Lactobacillus murinus derived IAAld-mediated macrophage polarization through NF-κB and TGF-β signaling.

  2025cites this paper
• Dietary tributyrin supplementation in Parkinson's disease: An open-label target engagement study.

  2025cites this paper
• Low-calorie diet intervention ameliorates gut microbiota dysbiosis and metabolic changes in obese patients with type 2 diabetes under standard care

  2025cites this paper
• The association of proton pump inhibitors and inflammatory bowel disease from the perspective of gut microbiota perturbation

  2025cites this paper
• Gut Microbiota and Short-Chain Fatty Acids: Key Factors in Pediatric Obesity and Therapeutic Targets

  2025cites this paper
• Type I interferons in inflammatory bowel diseases: balancing barrier integrity, repair and inflammation in the intestinal epithelium

  2025cites this paper
• Gut microbiome alterations and their clinical and biological implications in ovarian cancer: a systematic review

  2025cites this paper
• Exploring the prebiotic potential of dietary fibre concentrates from artichoke, red pepper, cucumber, and carrot by-products

  2025cites this paper
• Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota.

  2025cites this paper
• From the Gut to the Brain: Potential Novel Avenues for IBD Treatment Via Serotonergic Pathways.

  2025cites this paper
• Gut microbiota metabolites in the immunoregulation of enteritis: research progress

  2025cites this paper
• Butyrate ameliorates DSS-induced ulcerative colitis in mice by facilitating autophagy in intestinal epithelial cells and modulating the gut microbiota through blocking the PI3K-AKT-mTOR pathway

  2025cites this paper
• A Review of Global Patterns in Gut Microbiota Composition, Health and Disease: Locating South Africa in the Conversation

  2025cites this paper
• Conformable Device for Independent Measurements of Mucosal and Vascular Barriers in a Complex In Vitro Intestinal Model

  2025cites this paper
• Gut Microbiome and Paediatric Inflammatory Bowel Disease: Emerging Mechanistic and Therapeutic Insights Into Pathogenesis and Microbiota‐Based Approaches

  2025cites this paper
• The Role of Gut Microbiota and Mucin Barrier in the Pathogenesis of Colorectal Cancer

  2025cites this paper
• Causal effects of gut microbiota on IgG levels after Helicobacter pylori (H pylori) infection: Insights from genome-wide Mendelian randomization

  2025cites this paper
• Gut dysbiosis in early severe burns contributes to acute lung injury by impairing neutrophil chemotaxis.

  2025cites this paper
• Gut Microbiota Modulators as Antibiotic Alternatives in Broiler Nutrition: A Review

  2025cites this paper
• Microbiota in patients with cefuroxime resistance and anal fistula revealed by 16S ribosomal DNA

  2025cites this paper
• Unlocking the secrets of the human gut microbiota: Comprehensive review on its role in different diseases

  2025cites this paper
• Cancer, deuterium, and gut microbes: A novel perspective

  2025cites this paper
• Butyrate Supplementation Improves Intestinal Health and Growth Performance in Livestock: A Review

  2025cites this paper
• Taurine prevents mitochondrial dysfunction and protects mitochondria from reactive oxygen species and deuterium toxicity

  2025influential citation
• Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches

  2025cites this paper
• Sulfoquinovose is exclusively metabolized by the gut microbiota and degraded differently in mice and humans

  2025cites this paper
• Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights

  2025cites this paper
• Convergent evolution of oxidized sugar metabolism in commensal and pathogenic microbes in the inflamed gut

  2025cites this paper
• Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL)

  2025cites this paper
• Beneficial Effects of Butyrate on Kidney Disease

  2025cites this paper
• Evaluation of Anti-Inflammatory Effects of Six Ginsenosides and Rg1 Regulation of Macrophage Polarization and Metabolites to Alleviate Colitis

  2025cites this paper
• High Altitude Microbiome: Insight into Yak Gut Microbiota and its Nutritional and Functional Involvement for Food Systems

  2025cites this paper
• KG-Microbe - Building Modular and Scalable Knowledge Graphs for Microbiome and Microbial Sciences

  2025cites this paper
• Advances in intestinal epithelium and gut microbiota interaction

  2025cites this paper
• Gut Microbiota Serves as a Crucial Independent Biomarker in Inflammatory Bowel Disease (IBD)

  2025cites this paper
• Butyrate (short-chain fatty acid) alleviates lipopolysaccharide-binding proteins and improves physical function in knee osteoarthritis patients.

  2025cites this paper
• The interrelationship between intestinal immune cells and enteric α-synuclein in the progression of Parkinson’s disease

  2025cites this paper
• Bacterial dysbiosis and decrease in SCFA correlate with intestinal inflammation following alcohol intoxication and burn injury

  2025cites this paper
• Dietary butyric acid intake, kidney function, and survival: The National Health and Nutrition Examination Surveys ,2005-2018.

  2025cites this paper
• Colonic microbiome modulation and metabolic effects of Bryndza sheep cheese in pediatric acute lymphoblastic leukemia: An in vitro study

  2025cites this paper
• Multi-omics analysis of host-microbiome interactions in a mouse model of congenital hepatic fibrosis

  2025cites this paper
• The role of polysaccharides in immune regulation through gut microbiota: mechanisms and implications

  2025cites this paper
• Post-COVID Gut Dysbiosis and Its Role in Persistent Skin Disorders: A Gut–Skin Axis Perspective

  2025cites this paper
• Interplay of Neuroinflammation and Gut Microbiota Dysbiosis in Alzheimer’s Disease Using Diffusion Kurtosis Imaging Biomarker in 3 × Tg-AD Mouse Models

  2025cites this paper
• Obesity and Gut Microbiota: a succinct evaluation

  2025cites this paper
• Beyond the Gut: Unveiling Butyrate’s Global Health Impact Through Gut Health and Dysbiosis-Related Conditions: A Narrative Review

  2025cites this paper
• Recent developments in managing luminal microbial ecology in patients with inflammatory bowel disease: from evidence to microbiome-based diagnostic and personalized therapy

  2025cites this paper
• Sodium butyrate inhibits the expression of virulence factors in Vibrio cholerae by targeting ToxT protein

  2025cites this paper
• Role and Mechanism of Short-Chain Fatty Acids in Skeletal Muscle Homeostasis and Exercise Performance

  2025cites this paper
• Gut microbiota modulate intestinal inflammation by endoplasmic reticulum stress-autophagy-cell death signaling axis

  2025cites this paper
• Elevated butyric acid and histamine in feces and serum as an indicator of onset of necrotic enteritis in broiler chickens

  2025cites this paper
• Simulated digestion and fermentation characteristics of a polysaccharide from Momordica charantia L. and the anti-inflammatory activity of its fermentation products.

  2025cites this paper